IFNAR1 and Aicardi-Goutieres syndrome: In summary, this study demonstrates that Ifnar1 ASOs significantly reduced many key molecular, cellular and systems disease manifestations in a mouse model of cerebral interferonopathies, offering hope for individuals and families suffering from such conditions like AGS.